Trials / Conditions / Mature B-cell Malignancies
Mature B-cell Malignancies
4 registered clinical trials studyying Mature B-cell Malignancies — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in NCT06351527 | InnoCare Pharma Inc. | Phase 1 |
| Active Not Recruiting | Study of BGB-11417 in Adult Participants With Mature B-cell Malignancies NCT04883957 | BeiGene | Phase 1 |
| Active Not Recruiting | Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell Malignancies NCT04277637 | BeOne Medicines | Phase 1 |
| Completed | Study of Zanubrutinib in Japanese Participants With B-Cell Malignancies NCT04172246 | BeiGene | Phase 1 / Phase 2 |